DHA:IBNSINA'
s Dividend Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 2.86
Current: 2.02
During the past 0 years, the highest Dividend Yield of The IBN SINA Pharmaceutical Industry was 2.86%. The lowest was 0.00%. And the median was 0.00%.
DHA:IBNSINA's Dividend Yield % is ranked worse than 50.39% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.03
vs DHA:IBNSINA: 2.02
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The IBN SINA Pharmaceutical Industry Dividend Yield % Chart
The IBN SINA Pharmaceutical Industry Annual Data
Trend
Dividend Yield %
The IBN SINA Pharmaceutical Industry Semi-Annual Data
Dividend Yield %
DHA:IBNSINA vs IMNPQ: Dividend Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The IBN SINA Pharmaceutical Industry Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where The IBN SINA Pharmaceutical Industry's Dividend Yield % falls into.
The IBN SINA Pharmaceutical Industry Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
The IBN SINA Pharmaceutical Industry Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
BDT 6.400000
2025-10-27
2025-10-26
2026-01-01
Cash Dividend
annually
BDT:BDT 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Dividend Yield % of 2.02% as of Jun. 26, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. According to the industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #260 out of 516 companies in the Drug Manufacturers industry, placing it in the top 50.4%.
Is The IBN SINA Pharmaceutical Industry's Dividend Yield % too high?
The IBN SINA Pharmaceutical Industry's current Dividend Yield % is 2.02%. The Drug Manufacturers industry median Dividend Yield % is 2.03. The IBN SINA Pharmaceutical Industry's value of 2.02% is 0.5% below this industry median. Based on the distribution chart, The IBN SINA Pharmaceutical Industry ranks #260 out of 516 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Dividend Yield % compare to IMNPQ?
According to the Drug Manufacturers industry distribution chart, The IBN SINA Pharmaceutical Industry ranks #260 out of 516 companies for Dividend Yield %. This places The IBN SINA Pharmaceutical Industry in the lower half of its industry. The industry median Dividend Yield % is 2.03. The IBN SINA Pharmaceutical Industry's value of 2.02% is 0.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.03, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The IBN SINA Pharmaceutical Industry's current Dividend Yield % of 2.02% is 0.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The IBN SINA Pharmaceutical Industry's current Dividend Yield % is 2.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Dividend Yield % of 2.02%. The current Dividend Yield % is 2.02% and 0.5% below the Drug Manufacturers industry median of 2.03. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Dividend Yield % is 2.02% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The IBN SINA Pharmaceutical Industry Business Description
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
20GF Score
Get the complete analysis for DHA:IBNSINA
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DHA:IBNSINA has been successfully added to your 